Product Information
OSELTAMIVIR PHOS 45 MG CAPSULE is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.8309 per EA under NDC 68180067611. Its NADAC has been published 394 times since Apr 11, 2018.
Strength
45 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180067611
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
OSELTAMIVIR PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA208348On Market Since
2/9/2018
Pharmacological Classes
Price Statistics
The NADAC for OSELTAMIVIR PHOS 45 MG CAPSULE has been published 394 times since Apr 11, 2018, and over the history we have for it it has declined 89.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8309 per EA |
|---|---|
| All-time high | $8.1632 (Nov 14, 2018) |
| All-time low | $0.8309 (Jun 17, 2026) |
| 52-week high | $1.1740 |
| 52-week low | $0.8309 |
| Median price | $1.6276 |
| Average price | $2.7793 |
| Largest weekly change | +69.8% (Feb 22, 2023) |
| Weeks tracked | 394 |
| Tracking since | Apr 11, 2018 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of OSELTAMIVIR PHOS 45 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for OSELTAMIVIR PHOS 45 MG CAPSULE, manufactured by Lupin Pharmaceuticals Inc., is $0.8309 per EA (NDC 68180067611), effective Jun 24, 2026.
How has the price of OSELTAMIVIR PHOS 45 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for OSELTAMIVIR PHOS 45 MG CAPSULE has declined 89.5%. It has been tracked across 394 weekly CMS publications since Apr 11, 2018.
What are the highest and lowest recorded NADAC prices for OSELTAMIVIR PHOS 45 MG CAPSULE?
Since Apr 11, 2018, the NADAC for OSELTAMIVIR PHOS 45 MG CAPSULE has ranged from a low of $0.8309 (Jun 17, 2026) to a high of $8.1632 (Nov 14, 2018), with a median of $1.6276 per EA.
Are there cheaper alternatives to OSELTAMIVIR PHOS 45 MG CAPSULE?
2 NADAC-published products share the same active ingredient, strength, and dosage form as OSELTAMIVIR PHOS 45 MG CAPSULE, but none are currently priced below it.
Who manufactures OSELTAMIVIR PHOS 45 MG CAPSULE?
OSELTAMIVIR PHOS 45 MG CAPSULE (NDC 68180067611) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification